Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clonmel Healthcare is a leading Irish pharmaceutical company and a key subsidiary of the international STADA Group. Founded in 1970 and headquartered in Clonmel, County Tipperary, the company provides an extensive range of prescription generic medicines and over-the-counter (OTC) healthcare products. Its diverse portfolio covers major therapeutic areas such as cardiology, central nervous system, respiratory, and musculoskeletal health. Clonmel Healthcare plays a vital role in the Irish healthcare market by offering cost-effective alternatives to branded medications, supporting both community pharmacies and hospital sectors. The company is recognized for its strong distribution network and commitment to high-quality pharmaceutical standards. Through its parent company STADA, it also provides access to a growing range of biosimilar products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clonmel.